Showing results (271-280 of 365) with videos related to

Sort By:
Pageof 37
Lancet (London, England)|January 6, 2001
Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trialC L Loprinzi, J W Kugler, J A Sloan, et al.
Breast (Edinburgh, Scotland)|October 8, 2019
Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy (RU221511I); an ACCRU trialKathryn J Ruddy, Jennifer Le-Rademacher, Mario E Lacouture, et al.
Oncology|May 1, 1996
Randomized trial of dietician counseling to try to prevent weight gain associated with breast cancer adjuvant chemotherapyC L Loprinzi, L M Athmann, C G Kardinal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2004
Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapyThomas E Witzig, Peter T Silberstein, Charles L Loprinzi, et al.
Cancer|July 22, 2014
Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance)Debra L Barton, Gita Thanarajasingam, Jeff A Sloan, et al.
The Oncologist|August 10, 2022
Factors Associated With Physical Activity Levels in Patients With Breast CancerPaulina S Marell, Robert A Vierkant, Janet E Olson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1Charles L Loprinzi, Rui Qin, Ernie P Balcueva, et al.
Cancer Treatment Reviews|June 26, 2021
Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN)Daniel L Hertz, Daniel S Childs, Susanna B Park, et al.
The New England Journal of Medicine|February 4, 1999
Lack of effect of coumarin in women with lymphedema after treatment for breast cancerC L Loprinzi, J W Kugler, J A Sloan, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2007
Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4)Michele Y Halyard, Aminah Jatoi, Jeff A Sloan, et al.
Pageof 37